WO1994026771A1 - Process for the stereoselective preparation of l-alanyl-l-proline - Google Patents

Process for the stereoselective preparation of l-alanyl-l-proline Download PDF

Info

Publication number
WO1994026771A1
WO1994026771A1 PCT/US1994/005553 US9405553W WO9426771A1 WO 1994026771 A1 WO1994026771 A1 WO 1994026771A1 US 9405553 W US9405553 W US 9405553W WO 9426771 A1 WO9426771 A1 WO 9426771A1
Authority
WO
WIPO (PCT)
Prior art keywords
proline
process according
alanyl
pyruvyl
hydrogen
Prior art date
Application number
PCT/US1994/005553
Other languages
French (fr)
Inventor
Beverly W. Burbaum
Chunshi Li
George W. Matcham
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of WO1994026771A1 publication Critical patent/WO1994026771A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the dipeptide L-alanyl-L-proline is a known chemical intermediate useful in the preparation of various pharmaceutical agents having enzyme inhibiting proper- ties.
  • Angiotensin converting enzyme for example is a carboxyl terminal dipeptidyl exopeptidase [E.C. 3.4.15.1] which converts angiotensin I into angiotensin II, a potent vasoconstrictor.
  • Numerous compounds have been described which reduce blood pressure in humans by inhibiting the renin-angiotensin system (generally referred to as angiotensin converting enzyme inhibitors or simply ACE inhibitors) .
  • ACE inhibitors have a dipep ⁇ tide or tripeptide-type structure, typically but not invariably including an alanine component bound through its carboxy group to a nitrogen containing heterocyclic group in which a carboxy group is in the ⁇ -position to the nitrogen atom of the heterocyclic group.
  • Two exam ⁇ ples of such compounds are enalapril, which is N -[(S)-1- ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline, and enalaprilat, which is N 2 -[ (S)-l-carboxy-3-phenylpropyl]- L-alanyl-L-proline.
  • L-alanyl-L- proline is coupled with an alkyl ester of 2-oxo-4-phenyl- butyrate; see Blacklock et al . , J. Org. Chem . 53, 836-841 (1988) .
  • L-alanyl-L-proline contains two chiral centers and a third chiral center is generated in this condensa ⁇ tion.
  • the condensation is reported to provide high diastereoselectivity, the ratio of the desired SSS diastereoisomer to the unwanted RSS diastereoisomer is reported to be 87:13.
  • N-(t-butoxycarbonyl)-L-alanine can be coupled with the benzyl ester of L-proline in the presence of dicyclohexylcarbodiimide and the resulting benzyl ester of N-(t-butoxycarbonyl)-L-alanyl-L-proline treated with trifluoroacetic acid to remove the N-(t- butoxycarbonyl) group.
  • Hydrolysis to cleave the benzyl ester then yields L-alanyl-L-proline. See Klee ann et al . , Pharmazeutician Wirkstoffe , 1154 (1987).
  • the present invention pertains to a new process for the stereoselective preparation of L-alanyl-L-proline from inexpensive starting materials.
  • the process involves the hydrogenation, in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4, of an imine (including hydroxyimine) of the for ⁇ mula: CH 3
  • R is a hydrogenolytically labile group and R 1 is hydrogen or a hydrogenolytically removable carboxy protecting group.
  • the hydrogenolytically removable carboxy protecting groups encompassed by R-- typically are ester groups which are removable under sufficiently mild conditions of hydrogenation.
  • This can be for example a lower alkyl ester of 1 to 12 carbon atoms such as methyl or ethyl or
  • alkyl group which is (i) unsaturated such as vinyl or aryl, (ii ) branched such as t-butyl, or (Hi) substituted in the 1- or 2-position with lower alkoxy, such as for example, methoxymethyl, 1-methoxyethyl, and ethoxymethyl, lower alkylthio, such as for example
  • halogen such as 2,2,2-trichloroethyl, 2-bromoethyl and 2-iodoethoxycar- bonyl
  • one or two phenyl groups each of which can be unsubstituted or mono
  • R ⁇ ⁇ - is such a hydrogenolyti.cally remov ⁇ able carboxy protecting group, it is particularly advan ⁇ tageous that in the present process, the carboxy group in the proline portion of the molecule need not be pro ⁇ tected; i.e., R 1 can be hydrogen, thereby reducing the
  • Such groups include cyano, allylie groups (including cyclic allylic groups such as cyclohex-2-en-l- yl) , nitro, amino, alkoxy of 1 to 4 carbon atoms, hydroxy, carboxy, carbalkoxy, aryl such as phenyl and
  • naphthyl 125 naphthyl, and aralkyl such as benzyl, phenethyl and simi ⁇ lar groups as discussed above in greater detail in con- necti .on wi.th R ⁇ .
  • R preferably is hydroxy, alkyl, alkoxy, aralkyl, or aralkoxy and most preferably hydroxy.
  • reaction vessel of the hydrogenation simply through treatment of N-pyruvyl-L-proline with hydroxylamine thereby forming the hydroxyimine (or oxime) , as discussed in greater detail below.
  • a chiral R group such as (S)-(-)- ⁇ -phenethyl or (S)-(-)-l-(naphth-l-yl)ethyl,
  • the metal hydrogenolysis catalyst include known materials and typically are metals of Group 8 such as nickel, palladium, rhenium, platinum, or rhodium. Prepa ⁇ rations such as Raney nickel or palladium hydroxide can 145 be employed and the catalyst can be supported on carrier such as carbon or alumina. In order to achieve the desired stereoselectivity, the hydrogenation is carried out under strongly acidic conditions; i . e. , at a pH of less than about 4.
  • the reaction can be conducted in the presence or absence of an organic solvent.
  • the sol ⁇ vent can be any inert organic liquid in which the reac- tant is soluble and which is substantially inert to hydrogenation, as for example lower alkanols, alkanoic
  • the compounds of Formula I are readily prepared through treatment of N-pyruvyl-L-proline with an amine of the formula H2N-R.
  • the reaction can be conducted under conditions which remove 160 water, as for example through use of a Dean-Stark appara ⁇ tus or by addition of molecular sieves.
  • Typical amines include aminodiphenylmethane, naphth-1-ylmethylamine, benzylamine, hydroxylamine, S-(-)- ⁇ -phenethylamine, S-(- )-l-(l-naphthyl)ethylamine, and the like.
  • N-pyruvyl-L-proline can be prepared through any of 175 the known techniques.
  • the present invention also provides an improved process for the preparation of N-pyruvyl-L-proline (including carboxy protected N-pyruv- yl-L-proline derivatives) in which a compound of the formula: 180 CH 3
  • X and Y are chloro, bromo, iodo, or together alkyl- idenedioxy and R is hydrogen or a hydrogenolytically removable carboxy protecting group, is hydrolyzed at a pH range of from about 6.5 to about 8.5, preferably at a pH
  • R 1 is hydrogen and X and Y are chloro.
  • a compound of Formula II can be readily prepared by allowing L-proline and the corresponding 2-X-2-Y-prop- ionyl halide to react in the presence of sufficient aque ⁇ ous base to provide a pH of at least 9.
  • the 205 reaction is conducted in an inert organic solvent and ideally, there is sufficient aqueous base present to pro ⁇ vide a pH of at least 11.
  • the present invention permits stereoselective preparation of L-alanyl-L-proline through a four-step
  • N-pyruvyl-L-proline is treated with an amine to yield a compound of Formula I, and (iv) the latter is hydrogenated to yield L-alanyl-L-proline in high stereo- specificity.
  • N-pyruvyl-L-proline 0.085 g., 0.46 m oles, 1.0 eq.
  • N-pyruvyl-L-proline utilized as starting mate- 255 rial can be conveniently obtained from 2,2-dichloroprop- ionic acid according to the following procedure.
  • reaction mixture were transferred to a 1 L flask with an additional 200 mL of water as a rinse.
  • the methylene chloride was removed by evaporation and the pH adjusted to 2.
  • the solid Upon cooling to 0°C for 40 minutes, the solid
  • N-pyruvyl-L-proline (0.085 g. , 0.46 mmoles, 1.0 eq.), hydroxylamine hydrochloride (0.048 g. , 0.69 mmoles, 1.5 eq.), sodium acetate (0.056 g. , 0.69 mmoles, 1.5
  • reaction mixture can be accomplished by filtering the latter through Celite ® , adjusting the pH to 4, and con ⁇ centrating the resultant solution to one-half volume.
  • the solid which forms is collected by filtration, and held under vacuum to remove any residue solvent.
  • N-pyruvyl-L-proline 0.085 g. , 0.46 mmoles, 1.0 eq.
  • S-(-)- ⁇ -phenethylamine 0.110 g. , 0.91 mmoles, 2.0 eq.
  • 0.5 mL absolute ethanol 0.5 mL absolute ethanol.
  • reaction mixture was evacuated and purged with three cycles of hydrogen and then hydro ⁇ genated at 55 psi with shaking until the reaction was complete as indicated by HPLC.
  • reaction mixture was filtered through Celite ® on a B ⁇ chner funnel and the pH adjusted to 5.5 with 6 N sodium hydroxide.
  • the ethanolic aqueous solution was evacuated on a rotary evaporator keeping the temperature at ⁇ 42° C. Twenty milliliters of ethyl alcohol then were
  • the sodium chloride solids were fil ⁇ tered off using fine filter paper, and the filtrate was cooled to -5° C and seeded.
  • the white crystalline prod ⁇ uct was collected (96% d.e.) and washed with 20 mL cold ethanol (>99% d.e.). The sample was dried under vacuum
  • T.L.C. For L-alanine: IPA/water/Acetic acid 575 (70/20/ 30) . No L-alanine observed in sample.
  • L-proline IPA/water/ammonium hydroxide (70/30/ 20) . No L-proline observed in sample.

Abstract

L-alanyl-L-proline is stereoselectively prepared catalytically hydrogenating an N-(2-iminopropionyl)-L-proline in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4. Also disclosed are improved processes for production of N-pyruvyl-L-proline in which L-proline and a 2,2-disubstituted propionyl halide are allowed to react at a pH of at least 9 to produce an L-proline intermediate which is hydrolyzed at a pH range of from about 6.5 to about 8.5 to yield N-pyruvyl-L-proline.

Description

PROCESS FOR THE STEREOSELECTIVE PREPARATION OF L-ALANYL-L-PROLINE
Background of the Invention
The dipeptide L-alanyl-L-proline is a known chemical intermediate useful in the preparation of various pharmaceutical agents having enzyme inhibiting proper- ties. Angiotensin converting enzyme for example is a carboxyl terminal dipeptidyl exopeptidase [E.C. 3.4.15.1] which converts angiotensin I into angiotensin II, a potent vasoconstrictor. Numerous compounds have been described which reduce blood pressure in humans by inhibiting the renin-angiotensin system (generally referred to as angiotensin converting enzyme inhibitors or simply ACE inhibitors) .
Many of these synthetic ACE inhibitors have a dipep¬ tide or tripeptide-type structure, typically but not invariably including an alanine component bound through its carboxy group to a nitrogen containing heterocyclic group in which a carboxy group is in the α-position to the nitrogen atom of the heterocyclic group. Two exam¬ ples of such compounds are enalapril, which is N -[(S)-1- ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline, and enalaprilat, which is N2-[ (S)-l-carboxy-3-phenylpropyl]- L-alanyl-L-proline.
In one reported synthesis of enalapril, L-alanyl-L- proline is coupled with an alkyl ester of 2-oxo-4-phenyl- butyrate; see Blacklock et al . , J. Org. Chem . 53, 836-841 (1988) . L-alanyl-L-proline contains two chiral centers and a third chiral center is generated in this condensa¬ tion. Although the condensation is reported to provide high diastereoselectivity, the ratio of the desired SSS diastereoisomer to the unwanted RSS diastereoisomer is reported to be 87:13. The classical dipeptide synthesis in which the two amino acids in the form of protected derivatives are coupled and the two protecting groups are then removed also has been used in the preparation of L-alanyl-L- proline. For example, N-(t-butoxycarbonyl)-L-alanine can be coupled with the benzyl ester of L-proline in the presence of dicyclohexylcarbodiimide and the resulting benzyl ester of N-(t-butoxycarbonyl)-L-alanyl-L-proline treated with trifluoroacetic acid to remove the N-(t- butoxycarbonyl) group. Hydrolysis to cleave the benzyl ester then yields L-alanyl-L-proline. See Klee ann et al . , Pharmazeutische Wirkstoffe , 1154 (1987).
Blacklock et al . , supra , describe the preparation of L-alanyl-L-proline through the reaction of the unpro¬ tected proline (as the potassium salt) with a cyclic L- alanine N-carboxyanhydride, a 2,6-dioxo-4-substituted oxazolidine formed by the reaction of L-alanine and phos¬ gene. While this so-called NCA chemistry offers many advantages, it requires the use of phosgene and careful control of the reactants during the course of the reac¬ tion.
Mukaiyama et al . , Chemistry Letters , 1992, pages 181-184, describe the stereoselective preparation of var- ious dipeptides through the reduction of 2-hydroxyimino amides with the lanthanide samarium diiodide.
Detailed Description The present invention pertains to a new process for the stereoselective preparation of L-alanyl-L-proline from inexpensive starting materials. In particular, the process involves the hydrogenation, in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4, of an imine (including hydroxyimine) of the for¬ mula: CH3
I
C=N-R
I
75 C=0 I.
I
N
Figure imgf000005_0001
where R is a hydrogenolytically labile group and R1 is hydrogen or a hydrogenolytically removable carboxy protecting group.
85 The hydrogenolytically removable carboxy protecting groups encompassed by R-- typically are ester groups which are removable under sufficiently mild conditions of hydrogenation. This can be for example a lower alkyl ester of 1 to 12 carbon atoms such as methyl or ethyl or
90 such an alkyl group which is (i) unsaturated such as vinyl or aryl, (ii ) branched such as t-butyl, or (Hi) substituted in the 1- or 2-position with lower alkoxy, such as for example, methoxymethyl, 1-methoxyethyl, and ethoxymethyl, lower alkylthio, such as for example
95 "methylthiomethyl and 1-ethylthioethyl; halogen, such as 2,2,2-trichloroethyl, 2-bromoethyl and 2-iodoethoxycar- bonyl; one or two phenyl groups each of which can be unsubstituted or mono-, di- or tri-substituted with, for example lower alkyl such as tert.-butyl, lower alkoxy 100 such as methoxy, hydroxy, halo such as chloro, and nitro, such as for example, benzyl, 4-nitrobenzyl, diphenylmeth- yl, di-(4-methoxyphenyl)methyl; or aroyl, such as phenacyl.
While the process can be practiced with compounds of
105 Formula I in which Rι~- is such a hydrogenolyti.cally remov¬ able carboxy protecting group, it is particularly advan¬ tageous that in the present process, the carboxy group in the proline portion of the molecule need not be pro¬ tected; i.e., R1 can be hydrogen, thereby reducing the
110 number of synthetic steps by eliminating the need to remove such a protecting group.
The hydrogenolytically labile groups encompassed by R are described in, for example, Brieger, et al . , Chem. Rev. 74, 567 (1974); Johnstone, et al . , Chem. Rev. 85,
115 129 (1985) ; Augustine, "Catalytic Hydrogenation: Tech¬ niques and Applications in Organic Synthesis", Marcel Dekker, Inc., New York, 1965; Rylander, "Catalytic Hydro¬ genation in Organic Synthesis" , Academic Press, Inc., New York, 1979; and Sinfelt, Catal . Lett. , 9(3-4), 159-171
120 (1991) , the contents of which are incorporated herein by reference. Such groups include cyano, allylie groups (including cyclic allylic groups such as cyclohex-2-en-l- yl) , nitro, amino, alkoxy of 1 to 4 carbon atoms, hydroxy, carboxy, carbalkoxy, aryl such as phenyl and
125 naphthyl, and aralkyl such as benzyl, phenethyl and simi¬ lar groups as discussed above in greater detail in con- necti .on wi.th Rι .
It should be appreciated that the exact structure of R is unimportant insofar as completion of the reaction is
130 concerned since the group does not appear in the final compound. On the basis primarily of' cost, R preferably is hydroxy, alkyl, alkoxy, aralkyl, or aralkoxy and most preferably hydroxy. In this last regard, it is possible to form a compound of Formula I in situ , that is, in the
135 reaction vessel of the hydrogenation, simply through treatment of N-pyruvyl-L-proline with hydroxylamine thereby forming the hydroxyimine (or oxime) , as discussed in greater detail below. Moreover, a chiral R group such as (S)-(-)-α-phenethyl or (S)-(-)-l-(naphth-l-yl)ethyl,
140 can be used.
The metal hydrogenolysis catalyst include known materials and typically are metals of Group 8 such as nickel, palladium, rhenium, platinum, or rhodium. Prepa¬ rations such as Raney nickel or palladium hydroxide can 145 be employed and the catalyst can be supported on carrier such as carbon or alumina. In order to achieve the desired stereoselectivity, the hydrogenation is carried out under strongly acidic conditions; i . e. , at a pH of less than about 4.
150 The reaction can be conducted in the presence or absence of an organic solvent. When employed, the sol¬ vent can be any inert organic liquid in which the reac- tant is soluble and which is substantially inert to hydrogenation, as for example lower alkanols, alkanoic
155 acids, alkanes and the like.
The compounds of Formula I are readily prepared through treatment of N-pyruvyl-L-proline with an amine of the formula H2N-R. Optionally, but not necessarily, the reaction can be conducted under conditions which remove 160 water, as for example through use of a Dean-Stark appara¬ tus or by addition of molecular sieves. Typical amines include aminodiphenylmethane, naphth-1-ylmethylamine, benzylamine, hydroxylamine, S-(-)-α-phenethylamine, S-(- )-l-(l-naphthyl)ethylamine, and the like.
165 Conveniently, the treatment of N-pyruvyl-L-proline with an amine to form a compound of Formula I and the stereoselective hydrogenation to L-alanyl-L-proline can be conducted in the same reaction vessel, thereby mini¬ mizing equipment and potential transfer loss. In fact,
170 the entire reaction sequence described herein, from L- proline and a 2-X-2-Y-propionyl halide to L-alanyl-L- proline, can be conducted without the need to isolate or purify any of the intermediate products.
N-pyruvyl-L-proline can be prepared through any of 175 the known techniques. The present invention, however, also provides an improved process for the preparation of N-pyruvyl-L-proline (including carboxy protected N-pyruv- yl-L-proline derivatives) in which a compound of the formula: 180 CH3
I
X-C-Y
C=0 II.
185
Figure imgf000008_0001
190 where X and Y are chloro, bromo, iodo, or together alkyl- idenedioxy and R is hydrogen or a hydrogenolytically removable carboxy protecting group, is hydrolyzed at a pH range of from about 6.5 to about 8.5, preferably at a pH
195 of from about 7 to about 8. This pH range can be con¬ trolled through continued addition of base or acid as required or, more conveniently, through use of a buffer. Thus a compound of Formula II can simply be heated in an aqueous media to afford the desired N-pyruvyl-L-proline.
200 Preferably, R1 is hydrogen and X and Y are chloro.
A compound of Formula II can be readily prepared by allowing L-proline and the corresponding 2-X-2-Y-prop- ionyl halide to react in the presence of sufficient aque¬ ous base to provide a pH of at least 9. Preferably the 205 reaction is conducted in an inert organic solvent and ideally, there is sufficient aqueous base present to pro¬ vide a pH of at least 11.
Thus the present invention permits stereoselective preparation of L-alanyl-L-proline through a four-step
210 process in which (i) L-proline and a 2-X-2-Y-propionyl halide are allowed to react at a pH of at least 9 to pro¬ duce an N-(2-X-2-Y-propionyl)-L-proline, (ii ) this L- proline compound is hydrolyzed at a pH range of from about 6.5 to about 8.5 to yield N-pyruvyl-L-proline,
215 Hi ) N-pyruvyl-L-proline is treated with an amine to yield a compound of Formula I, and (iv) the latter is hydrogenated to yield L-alanyl-L-proline in high stereo- specificity. The following examples will serve to further typify 220 the nature of the invention but should not be construed as a limitation on the scope thereof which is defined solely by the appended claims.
In the following examples, the ratio of L-alanyl-L- proline to D-alanyl-L-proline was determined by HPLC
225 using a Waters 510 HPLC pump. Waters 712 WISP, Waters RCM 8 X 10 Novopak column. Waters 486 Tunable Absorbance Detector, and Shimadzu CR601 Chromatopac Recorder. A mixture of 19 parts of 0.15% aqueous phosphoric acid con¬ taining 10 mM octanesulfonic to one part isopropanol can
230 be used as eluant. The flow rate was 1.5 mL/minute with detection at 210 nm. The retention time of L-alanyl-L- proline is 22 minutes, that of D-alanyl-L-proline is 26 minutes. Gas chromatography employed a Supelco SPB-1 Column running at 75°C for 10 minutes, then 20°C per
235 minute, then 170°C for 5 minutes.
EXAMPLE 1
A. L-alanyl-L-proline
To a dry 5 mL flask was added N-pyruvyl-L-proline (0.085 g., 0.46 m oles, 1.0 eq.), naphth-1-ylmethylamine
240 (0.144 g. , 0.92 mmoles, 2.0 eq.) , and 2.0 mL absolute ethanol. After 3.0 hours at 25"C, the reaction mixture and 100 mL of ethanol were transferred under nitrogen to a 500 mL Parr shaker flask previously flushed with nitro¬ gen. Palladium-on-carbon (0.02 g. , 0.18 mmoles, 0.4 eq.)
245 was added together with 50 mL absolute ethanol. Nitrogen was bubbled through the suspension for 5 minutes and the mixture then hydrogenated at 50 psi for 22 hours using three alternating vacuum/hydrogen gas cycles. The reac¬ tion mixture was filtered through Celite® and concen-
250 trated to a yellow oil which was analyzed by HPLC to show an 88% conversion (yield) and a 31% diastereomeric excess of L-alanyl-L-proline. Unreacted imine is the other major peak (5%) . The N-pyruvyl-L-proline utilized as starting mate- 255 rial can be conveniently obtained from 2,2-dichloroprop- ionic acid according to the following procedure.
B. 2.2-Dichloropropionyl Chloride
To a dry 100 mL 3-necked flask under nitrogen were added 2,2-dichloropropionic acid (50 g. , 0.35 moles, 1
260 eg-) and dimethylformamide (4 mL, 0.05 moles, 0.15 eq.). Thionyl chloride (35 mL, 0.49 moles, 1.4 eq.) then was added dropwise over 30 minutes. The reaction mixture was warmed to 55°C for two hours while being following by gas chromatography with methanol quench to insure disappear-
265 ance of dichloropropionic acid (retention time 8.5 min¬ utes). 2,2-dichloropropionyl chloride was distilled at 120-121°C to give 51.7 g. (92% yield) of a slightly yel¬ low oil.
C. N- (2, 2 -Di chl oropropi onyl ) prol ine
270 To a dry 250 L 3-necked flask were added L-proline
(27 g. , 0.235 moles, 1.0 eq.) and 100 mL of 6 N sodium hydroxide. The solution (pH = 14) was cooled to below 10°C in an ice bath. A solution of dichloro- propionylchloride (51.7 g., 0.32 moles, 1.37 eq.) in 40
275 mL of methylene chloride then was added over 60 minutes keeping the solution temperature below 10°C (pH = 11 after addition). The remaining 2,2-dichloroprop- ionylchloride was rinsed in with an additional 20 mL of methylene chloride and the reaction mixture then warmed
280 to at least 22°C and stirred for 60 minutes, then the reaction mixture were transferred to a 1 L flask with an additional 200 mL of water as a rinse. The methylene chloride was removed by evaporation and the pH adjusted to 2. Upon cooling to 0°C for 40 minutes, the solid
285 which forms was collected by filtration using cold water as a rinse to yield N-(2,2-dichloropropionyl)proline which was dried under vacuum (0.1 Torr) for 15 hours to give 44.3 g. (78% yield) which can be further purified through recrystallization from ethyl acetate or ethyl 290 acetate:hexane. .p. 61 - 62°C
Elemental Analysis: (C8H11NO3CI2) ; Calculated : C 39.99, H 4.62, N 5.83, Cl 29.58; Found: C 39.98, H 4.59, N 5.78, Cl 29.43.
1 H NMR (CDCI3, S ) : 6.40 (br s, 2 H, 1/2 H20, COOH) , 295 4.49 (dd, 1H, J = 5.0, 8.4 Hz, HCCOO), 4.17-4.03 (m, 2 H, CH2 pro), 2.30 (80%), 2.24 (20%) (s, 3 H, Me), 2.15-1.96 (m, 4 H, CH2 pro) .
1 H NMR (CD3OD, S ) : 4.43 (dd, 1H, J = 5.1, 8.8 Hz, HCCOO), 4.23-4.13 (m, 1 H, CH2 pro), 4.09-3.98 (m, 1 H, 300 CH2 pro), 2.26 (s, 3 H, Me), 2.13-1.90 (m, 4 H, CH2 pro).
13 C NMR (CDCI3, δ ) : 176.2, 164.4, 80.5, 61.4, 49.5, 35.4, 28.3, 25.7.
D. N-pyruvyl-L-proline
To a dry 500 mL 3-necked flask were added 305 dichloropropionylproline (8.9 g. , 37.0 mmoles), 125 mL of 0.7 M phosphate buffer (pH = 7.4) and 50 mL of water. The reaction mixture was heated to reflux with stirring, maintaining the pH at 7.4 ±0.1, for 18 hours. HPLC indi¬ cated 90% N-pyruvyl-L-proline (retention time 3.5 min- 310 utes) and 0.4% N-(2,2-dichloropropionyl)-proline (retention time 8.3 minutes).
The pH was adjusted to 3 and the mixture was extracted six times with 150 mL ethyl acetate. The com¬ bined organic layers were dried over magnesium sulfate,
315 filtered, and concentrated to yield a yellow oil (4.85 g. , 71%) which was dissolved in 100 mL of ethyl acetate, treated with charcoal, filtered through Celite® and con¬ centrated. Ethyl acetate (200 mL) was added and the mix¬ ture concentrated seven to ten times. Crystallization
320 was obtained by cooling with ethyl acetate to give 4.0 g. (58% yield) of white solid N-pyruvyl-L-proline, m.p. 88- 89°C.
Elemental Analysis: (C8H11NO4) ; Calculated C 51.88, H 6.00, N 7.56; Found: C 51.61, H 6.06, N 7.37.
325 1 H NMR (CDCI3, δ ) : 5.21 (br s, 3 H, H20, COOH) ,
4.90 (dd, 1H, J = 5.1, 7.8 Hz, HCCOO), 3.85-3.57 (m, 2 H, CH2 pro), 2.47 (60%, s, 3 H, Me), 2.43 (40%, s, 3 H, Me), 2.32-1.89 (m, 4 H, CH2 pro).
13 C NMR (CDCI3, <S) : 198.0 (45%), 197.2 (55%), 176.2 330 (55%), 175.4 (45%), 162.5 (51%), 162.3 (49%), 59.6 (55%), 59.5 (45%), 49.2 (40%), 47.6 (60%), 31.4 (65%), 28.3 (35%), 27.0 (45%), 26.5 (55%), 25.1 (40%), 21.9 (60%).
When instead 2 L of acetic acid were added prior to reduction with hydrogen over palladium-on-carbon in the 335 above example, a 45% diastereomeric excess of L-alanyl-L- proline was obtained.
By substituting D-proline for L-proline in the above example, a 70% diastereomeric excess mixture of D-alanyl- D-proline and L-alanyl-D-proline was obtained.
340 EXAMPLE 2
By substituting 0.168 g. (0.92 mmoles, 2.0 eq.) of aminodiphenylmethane for naphth-1-ylmethylamine in the procedure of Example 1, Part A, a 30% diastereomeric excess of L-alanyl-L-proline was obtained.
345 EXAMPLE 3
To a dry 5 mL flask was added N-pyruvyl-L-proline
(0.085 g. , 0.46 mmoles, 1.0 eq.), benzylamine (0.098 g. ,
0.9 mmoles, 2.0 eq.), and 2.0 mL absolute ethanol. After
3.0 h. at 25°C, the reaction mixture and 100 mL of
350 ethanol were transferred under nitrogen to a 500 mL Parr shaker flask previously been flushed with nitrogen. Palladium hydroxide (0.02 g. , 0.18 mmoles, 0.4 eq.) was added together with acetic acid (0.5 mL, 8.7 mmoles, 19 eq.). Nitrogen was bubbled through the suspension for 5
355 minutes and the mixture then hydrogenated at 50 psi for 24 hours using three alternating vacuum/hydrogen gas cycles. The reaction mixture was filtered through Celite® and concentrated to a yellow oil which when ana¬ lyzed (HPLC) demonstrated a 52% diastereomeric excess of
360 L-alanyl-L-proline.
EXAMPLE 4
N-pyruvyl-L-proline (0.085 g. , 0.46 mmoles, 1.0 eq.), hydroxylamine hydrochloride (0.048 g. , 0.69 mmoles, 1.5 eq.), sodium acetate (0.056 g. , 0.69 mmoles, 1.5
365 eq and 2 L water and 10 mL ethanol were added to a 25 mL flask. The suspension was heated to reflux for 2 h. The imine was transferred under nitrogen gas with 100 mL ethanol to a 250 mL Parr flask. Palladium hydroxide-on- carbon (0.02 g. , 0.18 mmoles, 0.4 eq.) and hydrochloric
370 acid (6 mL, 0.2 moles, 430 eq.) were added and nitrogen was bubbled through for 3 minutes (pH = 0.1). The mate¬ rial was hydrogenated for 17 hours as described in Exam¬ ple 1, Part A, to produce a >99.5% diastereomeric excess of L-alanyl-L-proline. Isolation of the product from the
375 reaction mixture can be accomplished by filtering the latter through Celite®, adjusting the pH to 4, and con¬ centrating the resultant solution to one-half volume. The solid which forms is collected by filtration, and held under vacuum to remove any residue solvent.
380 When the reaction of this example was conducted in the absence of water, a >99.5% diastereomeric excess of L-alanyl-L-proline was obtained.
When conducted in the presence of acetic acid (2 mL, 35 mmoles, 76 eq.) so that the pH was 2.8, a 71% diaster- 385 eomeric excess of L-alanyl-L-proline was obtained. When conducted in the absence of acid, pH = 4.65, a 33% diastereomeric excess of L-alanyl-L-proline was obtained.
EXAMPLE 5
390 By following the procedure described in Example 4 but utilizing the following hydrogenolysis catalysts, the indicated diastereomeric excesses of L-alanyl-L-proline were obtained:
395 Hydrogenolysis Diastereomeric Catalysts Excess
Raney nickel/acetic acid 32 %
400 rhenium-on-carbon >99.5% palladium-on-carbon >99.5% platinum-on-carbon >99.5%
405 rhodium-on-carbon >99.5% rhodium-on-alumina 47 %
410 EXAMPLE 6
To a dry 5 mL flask was added N-pyruvyl-L-proline (0.085 g. , 0.46 mmoles, 1.0 eq.), S-(-)-α-phenethylamine (0.110 g. , 0.91 mmoles, 2.0 eq.), and 0.5 mL absolute ethanol. After stirring for 3.25 hours at 25°C, the
415 reaction mixture was transferred under nitrogen to a 250 mL Parr shaker flask which previously had been flushed with nitrogen. Raney nickel (0.01 g., 0.17 mmoles, 0.4 eq.) in water was washed with absolute ethanol three times on a Buchner funnel under vacuum and added to the
420 Parr flask with 50 mL absolute ethanol. Nitrogen was bubbled through the suspension for 5 minutes and acetic acid (0.5 mL, 8.7 mmoles, 19 eq.) was added. Nitrogen was bubbled for an additional 2 minutes. The material was hydrogenated at 50 psi (with three alternating vac- 425 uum/hydrogen gas cycles) for 16.5 hours and then filtered through Celite® into a fresh 500 mL Parr flask, washing with 200 mL absolute ethanol. After bubbling nitrogen through the mixture, palladium hydroxide-on-carbon (0.02 g. , 0.18 mmoles, 0.4 eq.) was added and the mixture then
430 hydrogenated for 5.25 hours at 50 psi (after three evacuation/hydrogen gas at 50 psi cycles) . The reaction mixture was filtered through Celite® and concentrated to a yellow oil. HPLC determination of a solution in abso¬ lute ethanol established a 94% diastereomeric excess of
435 L-alanyl-L-proline.
EXAMPLE 7
By following the procedure of Example 6 but using S- (-)-l-(naphth-l-yl)ethylamine (0.157 g., 0.91 mmoles, 2.0 eq.) in place of S-(-)-α-phenethylamine and heating the 440 initial reaction mixture 3 hours while conducting the reductions for 16 hours with Raney Nickel and 21 hours for palladium hydroxide-on-carbon, a diastereomeric excess of >99% was obtained for L-alanyl-L-proline as shown by HPLC.
445 By following the procedure described in the above example but using R-(+)-l-(naphth-l-yl)ethylamine in place of S-(-)-l-(naphth-l-yl)ethylamine to make the imine of N-pyruvyl-L-proline, a 34% diastereomeric excess of L-alanyl-L-proline was obtained.
450 EXAMPLE 8
By following the procedure described in Example 4 but using the benzyl ester of N-pyruvyl-L-proline (0.4 g, 1.45 mmoles, 1.0 eq.), a 71% diastereomeric excess of L- alanyl-L-proline was obtained.
455 Additionally, by following the procedure described in Example 4 but using either 0-methoxyhydroxyl or O-benzylhydroxyl amine to synthesize the methoxyl or benzoxylamine of N-pyruvyl-L-proline, a 75% or 47% diastereomeric excess of L-alanyl-L-proline was obtained, 460 respectively.
Moreover, by following the procedure described in Example 4 but using ammonium acetate to make the acetyli ine of N-pyruvyl-L-proline, a 65% diastereomeric excess of L-alanyl-L-proline was obtained.
465 EXAMPLE 9
To 2,2-dichloropropionic acid (200 g. , 1.4 moles, 1.4 equiv.) and dimethylformamide (16 mL) was added, dropwise over 20 minutes, 147 L of thionyl chloride. The reaction mixture then was warmed to 75° C for two 470 hours and monitored by gas chromatography with methanol quench until disappearance of dichloropropionic acid (retention time 8.5 min.), to yield dichloropropionyl chloride as a slightly yellow oil.
EXAMPLE 10
475 To a dry reaction vessel werte added L-proline (115 g. , 1.0 moles, 1.0 eq.), 144 mL of 6 N sodium hydroxide and 20 g. solid sodium hydroxide. The clear, colorless solution (pH = 11.5) was cooled to +10° C in an ice bath with stirring. All of the above 2,2-dichloropropionyl
480 chloride was diluted with 50 mL methylene chloride and added to the L-proline solution over 2 hours, keeping the solution temperature below +10 C° and the pH at 11.5 by simultaneous addition of 290 mL of 6 N sodium hydroxide to yield 2,2-dichloropropionyl-L-proline. The pH was
485 adjusted to 3 by the addition of 216 mL of 6 N hydro¬ chloric acid. The solid which formed was collected by filtration using 300 mL of 6 N hydrochloric acid as a wash to yield white crystalline 2,2-dichloropropionyl-L- proline which was dried under vacuum (30 Torr) for 18
490 hours to give 216 g. (90% yield based on L-proline) . HPLC at 23 minutes showed >96% purity. The recrys- tallization from ethyl acetate or ethyl acetate-hexane removes 0.5 mole of water but does not significantly improve purity, m.p. 61-62° C.
Elemental analysis: (C8HnNθ3Cl2) ; Calculated: C 39.99, H 4.62, N 5.83, Cl 29.58; Found: C 39.98, H 4.59, N 5.78, Cl 29.43.
-"H NMR (CDC13, δ ) : 6.40 (br S, 2 H, 1/2 H20, COOH) , 4.49 (dd, 1H, J=5.0, 8.4 Hz, HCCOO), 4.17-4.03 (m, 2H, CH2 pro), 2.30 (80%), 2.24 (20%) (s 3H, Me), 2.15-1.96 (m, 4H, CH2 pro) .
13C NMR (CDCL3, δ) : 176.2, 164.4, 80.5, 61.4, 49.5, 35.4, 28.3, 25.7.
EXAMPLE 11
To a dry reaction vessel were added 2,2-dichloro- propionyl-L-proline (8.9 g. , 37.0 mmoles) and 125 mL of deionized water. The pH of the mixture was adjusted to 7.2 and heated at reflux with stirring, maintaining the pH at 7.2 - 7.8, for 16 hours. HPLC indicated 92% pyru- vyl-L-proline (retention time 2.8 minutes) and <0.4% 2,2- dichloropropionyl-L-proline (retention time 23 minutes) .
The pH was adjusted to 1.5 and pyruvyl-L-proline was extracted from the aqueous solution six times with 150 mL ethyl acetate. The combined organic layers were dried over magnesium sulfate, filtered and concentrated to yield a yellow oil (6.11 g., 89%), which was then dried. Crystallization was obtained with ethyl acetate to give 4.0 g. (58% yield) of white solid pyruvyl-L-proline. m.p. 88-89° C.
Elemental Analysis:
Figure imgf000017_0001
; Calculated: C 51.88,
H 6.00, N 7.56; Found: C 51.61, H 6.06, N 7.37. ^-H NMR (CDCL3, <S) : 5.21 (br S, 3 H, H2Of COOH) , 4.90 (dd, 1H, J = 5.1, 7.8 Hz, HCCOO), 3.85-3.57 (m, 2 H, CH2 pro), 2.47 (60%, s, 3 H, Me), 2.43 (40%, s, 3 H, Me), 525 2.32-1.89 (m, 4 H, CH2 pro).
13C NMR (CDCL3, δ ) : 198.0 (45%), 197.2 (55%), 176.2 (55%), 175.4 (56%), 162.5 (51%), 162.3 (49%), 59.6 (55%), 59.5 (45%), 49.2 (40%), 47.6 (60%), 31.4 (65%), 28.3 (35%), 27.0 (45%), 26.5 (55%), 25.1 (40%), 21.9 (60%).
530 EXAMPLE 12
To a dry reaction vessel were added 2,2- dichloropropionyl-L-proline (216 g. , 0.9 moles, 1,0 equiv.), hydroxylamine hydrochloride (75 g. , 1.1 moles, 1.2 equiv.), and 230 mL of 6 N sodium hydroxide plus 5 g.
535 solid sodium hydroxide (to achieve a pH of 7.2). The clear yellow solution was heated to reflux at 110° C with a condenser, with constant stirring and a pH controller to keep the pH at 7.2. The course of reaction was followed by HPLC (about 13 hours) . A pH controller was
540 attached to 6 M sodium hydroxide and 350 mL of sodium hydroxide was used. HPLC indicated <0.6% of 2,2- dichloropropionyl-L-proline (retention time 23 minutes) and 88-92% oxime (retention time 2.8 minutes).
EXAMPLE 13
545 To a reaction vessel were added 10 g. pyruvyl-L- proline (54 mmole) , 5 g. hydroxylamine hydrochloride (72 mmole) , 40 mL deionized water, 120 mL ethyl alcohol and 2.9 g. of sodium hydroxide. The reaction mixture was stirred (pH 5.0 after solubilized) and then refluxed for
550 2.5 hours. The disappearance of starting material can be followed by gas chromatography. After cooling to room temperature, the reaction mixture was transferred to a 2 L Parr shaker flask with 20 mL ethanol as a rinse. To the flask were added 0.45 1 of 0.1 N hydrochloric acid
555 (the pH of the reaction mixture is 2) and 5 g. of 5% palladium-on-carbon. The reaction mixture was evacuated and purged with three cycles of hydrogen and then hydro¬ genated at 55 psi with shaking until the reaction was complete as indicated by HPLC.
560 The reaction mixture was filtered through Celite® on a Bύchner funnel and the pH adjusted to 5.5 with 6 N sodium hydroxide. The ethanolic aqueous solution was evacuated on a rotary evaporator keeping the temperature at <42° C. Twenty milliliters of ethyl alcohol then were
565 added to the solid. The sodium chloride solids were fil¬ tered off using fine filter paper, and the filtrate was cooled to -5° C and seeded. The white crystalline prod¬ uct was collected (96% d.e.) and washed with 20 mL cold ethanol (>99% d.e.). The sample was dried under vacuum
570 to give 6.5 g. L-alanyl-L-proline (>99% chemical purity by HPLC) .
HPLC (retention times): 19.9 min. L-alanyl-L-pro¬ line and 27.0 min. d-alanyl-L-proline.
T.L.C.: For L-alanine: IPA/water/Acetic acid 575 (70/20/ 30) . No L-alanine observed in sample.
For L-proline: IPA/water/ammonium hydroxide (70/30/ 20) . No L-proline observed in sample.
E NMR (CD30D and D20, δ ) : 4.4-4.2 (m, 1.4 H) , 3.94
(q, 0.4 H, J = 7 Hz), 3.68-3.50 (m, 1.3 H) , 3.52-3.40 (m,
580 0.7 H) , 3.35-3.30 (m, 0.4 H) , 2.4-2.2 (m, 1.6 H) , 2.00-
1.86 (m, 2.5 H) , 1.56 (40%, d, 3H, Me), 1.45 (60%, d, 3H,
Me) .
13C NMR (CD3OD and D20, 5): 179.5, 179.0, 170.3, 169.3, 63.2, 63.0, 49.2, 49.1, 48.3, 48.2, 32.6, 30.4, 585 25.7, 23.2, 16.5, 16.1.

Claims

What is claimed is:
1. Process for the stereoselective preparation of L- alanyl-L-proline which comprises hydrogenating, in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4, an imine of the formula:
CH3
I
C=N-R
I c=o
I N
Figure imgf000020_0001
wherein R is a hydrogenolytically labile group and R1 is hydrogen or a hydrogenolytically removable carboxy protecting group.
2. The process according to claim 1 wherein R is hydrogen.
3. The process according to claim 1 wherein R is selected from the group consisting of hydroxy, alkyl, alkoxy, aralkyl, and aralkoxy.
4. The process according to claim 1 in which R is hydroxy.
5. The process according to claim 4 in which said imine is formed in situ from the reaction of hydroxylamine and N-pyruvyl-L-proline.
6. The process according to claim 1 in which R is chiral.
7. The process according to claim 1 in which the metal hydrogenolysis catalyst is Raney nickel or a catalyst comprising palladium, rhenium, platinum, or rhodium.
8. Process for the preparation of an L-proline compound of the formula:
Figure imgf000021_0001
COOR1
wherein X and Y are chloro, bromo, iodo, or together alkylidenedioxy and R1 is hydrogen or a hydrogenolytically removable carboxy protecting group, which comprises allowing L-proline and the corresponding 2-X-2-Y-propionyl halide to react in the presence of sufficient aqueous base to provide a pH of at least 9.
9. The process according to claim 8 wherein the L-proline and 2-X-2-Y-propionyl halide are allowed to react in an inert organic solvent.
10. The process according to claim 8 wherein sufficient aqueous base is present to provide a pH of at least 11.
11. Process for the preparation of N-pyruvyl-L-proline or a carboxy protected N-pyruvyl-L-proline which comprises hydrolyzing a compound of the formula:
Figure imgf000021_0002
COOR1
wherein X and Y are chloro, bromo, iodo, or together alkylidenedioxy and R1 is hydrogen or a hydrogenolytically removable carboxy protecting group, at a pH range of from about 6.5 to about 8.5.
12. The process according to claim 11 wherein R1 is hydrogen.
13. The process according to claim 11 wherein X and Y are chloro.
14. A compound of the formula:
CH3
I ccι2
I
C=0
I
Figure imgf000022_0001
wherein R1 is hydrogen or a hydrogenolytically removable carboxy protecting group.
PCT/US1994/005553 1993-05-18 1994-05-18 Process for the stereoselective preparation of l-alanyl-l-proline WO1994026771A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/063,434 1993-05-18
US08/063,434 US5319098A (en) 1993-05-18 1993-05-18 Process for the stereoselective preparation of L-alanyl-L-proline

Publications (1)

Publication Number Publication Date
WO1994026771A1 true WO1994026771A1 (en) 1994-11-24

Family

ID=22049164

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/005553 WO1994026771A1 (en) 1993-05-18 1994-05-18 Process for the stereoselective preparation of l-alanyl-l-proline

Country Status (2)

Country Link
US (2) US5319098A (en)
WO (1) WO1994026771A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319098A (en) * 1993-05-18 1994-06-07 Celgene Corporation Process for the stereoselective preparation of L-alanyl-L-proline
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5846979A (en) * 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US20010049381A1 (en) * 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
CZ291417B6 (en) * 1997-08-06 2003-03-12 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Process for preparing N-pyruvyl-L-proline
AT405399B (en) * 1997-08-06 1999-07-26 Chemie Linz Gmbh Process for the preparation of 1-pyruvoyl-L-proline
AT405400B (en) * 1997-11-12 1999-07-26 Chemie Linz Gmbh Process for the preparation of 1-pyruvoyl-L-proline
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
JP2002516843A (en) * 1998-06-03 2002-06-11 ジー・ピー・アイ ニイル ホールディングス インコーポレィティッド Heterocyclic ester and amide hair growth compositions and uses thereof
US6331537B1 (en) * 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6376517B1 (en) 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6337340B1 (en) 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US6399648B1 (en) 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6339101B1 (en) 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
AR021803A1 (en) * 1998-09-23 2002-08-07 Merck & Co Inc PERFECTED STEREOSELECTIVE PROCESS FOR ENALAPRIL.
US20050106703A1 (en) * 2003-11-05 2005-05-19 Kyowa Hakko Kogyo Co., Ltd. Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3701209A1 (en) * 1986-01-17 1987-07-23 Otsuka Pharma Co Ltd PROLIN DERIVATIVES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943640A (en) * 1983-10-14 1990-07-24 The Dow Chemical Company Preparation of 5-(1-alkyl-carbonyloxy)alkylpyrrolidin-2-one
JPS6485994A (en) * 1987-05-29 1989-03-30 Hamari Yakuhin Kogyo Kk Nepsilon-trifluoroacetyl-l-lysyl-l-proline-d-10-camphor sulfonic acid salt and production thereof
DE4123248C2 (en) * 1991-07-13 1996-03-07 Degussa Process for the preparation of N-substituted alpha-amino acids and alpha-amino acid derivatives
US5319098A (en) * 1993-05-18 1994-06-07 Celgene Corporation Process for the stereoselective preparation of L-alanyl-L-proline

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3701209A1 (en) * 1986-01-17 1987-07-23 Otsuka Pharma Co Ltd PROLIN DERIVATIVES

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Columbus, Ohio, US; *

Also Published As

Publication number Publication date
US5424454A (en) 1995-06-13
US5319098A (en) 1994-06-07

Similar Documents

Publication Publication Date Title
US5424454A (en) Process for the stereoselective preparation of l-alanyl-l-proline
US7531673B2 (en) Preparation of amino acid amides
Freidinger Synthesis of. gamma.-lactam-constrained tryptophyl-lysine derivatives
CA1329445C (en) Process for preparing n-[1(s)-ethoxycarbonyl-3- phenylpropyl]-l-alanyl-l-proline
CA1244041A (en) Process for the preparation of cis, endo- octahydrocyclopenta¬b|pyrrole-2-carboxylate
AU703927B2 (en) 7-amino-2-heptenoates and their use in the preparation of methylphenidate
EP1546149A1 (en) Modified pictet-spengler reaction and products prepared therefrom
GB2086393A (en) Bicyclic compounds
MXPA98007879A (en) 7-amino-2-heptenoatos and its use in the preparation of metilfenid
DE60209458T2 (en) Process for the synthesis of (2S, 3aS, 7aS) -1- (S) -alanyl-octahydro-1H-2-carboxylic acid derivatives and use in the synthesis of perindopril
JPH07304770A (en) New benzazepinone derivative
IE55872B1 (en) Derivatives of omega-amino acids,the preparation and utilisation thereof,and the compositions containing these derivatives
JP2002507624A5 (en)
US7935831B2 (en) Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic Acid Derivatives
AU2003224420B2 (en) Process for preparation of perindopril and salts thereof
US6034247A (en) Oxazolidinones and methods for the synthesis and use of same
EP0239062B1 (en) N2-(1-carboxy-3-oxo-3-phenylpropyl)-l-lysine compounds and their derivatives
BG64050B1 (en) Method for preparing aminoderivatives of alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
JPH09208558A (en) Production of optically active 4-hydroxy-2-pyrrolidone
Kaptein et al. Synthesis of dipeptides containing α‐substituted amino acids; their use as chiral ligands in Lewis‐acid‐catalyzed reactions
US5959141A (en) 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
Achatz et al. Asymmetric Synthesis Employing a Chiral 5‐Methoxy‐1, 4‐oxazin‐2‐one Derivative: Preparation of Enantiomerically Pure α‐Quaternary α‐Amino Acids
Chen et al. Total synthesis of cis, cis-ceratospongamide
WO1998035934A1 (en) η-OXO-HOMOPHENYLALANINE DERIVATIVES AND PROCESS FOR PRODUCING HOMOPHENYLALANINE DERIVATIVES BY REDUCING THE SAME
US5710322A (en) Optically active iminocarboxylic acid derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA